[
    "{\"step_by_step_thinking\": \"Tocilizumab is a monoclonal antibody that targets the interleukin-6 (IL-6) receptor. It is used to treat various autoimmune conditions, including rheumatoid arthritis and cytokine release syndrome. Tumor necrosis factor (TNF) inhibitors, on the other hand, target TNF-alpha, a different cytokine involved in inflammation. Therefore, tocilizumab is not a tumor necrosis factor inhibitor.\", \"answer_choice\": \"B. no\"}"
]